NPS

Clinical trials for NPS explained in plain language.

Never miss a new study

Get alerted when new NPS trials appear

Sign up with your email to follow new studies for NPS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Could cannabis calm Alzheimer's agitation? new trial seeks answers

Symptom relief Recruiting now

This study tests an oral medication called IGC-AD1, made from a cannabis compound (THC), to see if it safely reduces agitation in people with mild to severe Alzheimer's dementia. About 164 participants will take the drug or a placebo twice daily for several weeks. The goal is to …

Matched conditions: NPS

Phase: PHASE2 • Sponsor: IGC Pharma, LLC • Aim: Symptom relief

Last updated May 26, 2026 06:21 UTC

NPS

Get alerted when new NPS trials appear

Could cannabis calm Alzheimer's agitation? new trial seeks answers